TwinStrand Biosciences (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 07, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Company Description
- TwinStrand's biochemistry and software-based solution enables researchers and clinicians to detect genetic 'needles in a haystack.' By identifying ultra-low frequency DNA mutations with a resolution 10,000-fold greater than conventional tools on the market, TwinStrand enables detection, quantification, and characterization of variants that were previously undetectable.
- Market
- Genetic Research and Clinical Diagnostics
- Location
- Seattle, WA, USA
- Coinvestors
- Alexandria Venture Investments, Madrona Venture Group, Ridgeback Capital Management